02 / LONG-ACTING GH RESEARCH
CJC-1295: What it raises and what remains unknown
Researchers made this compound to outlast your body’s growth-hormone message. You’ll see what rose, what didn’t improve, and why your long-term risk is unknown.
What the compound raised after researchers made it
Researchers started with your body’s growth-hormone message. They changed it so your body wouldn’t break it down fast.
The result was CJC-1295. It tells your growth gland to send out growth hormone.
The long form attaches to albumin, one of your blood proteins. The shorter form doesn’t have the added chemical part.
The albumin link can keep the compound working for days. The shorter form wears off sooner.
Two studies in people measured blood changes [9][10]. Growth hormone and growth factor 1, a liver-made growth signal, both rose.
Those studies didn’t show that people felt healthier. They also didn’t settle harm over years.
No Phase 3 trial, the large confirming test, followed. Drug testing ended without approval.
In 2024, federal advisers raised safety concerns. They didn’t support custom batches made by local pharmacies [6].
CJC-1295 is still sold with research labels; a prescription request instead calls for a licensed clinician’s assessment. Sport rules also ban it.
The study amounts below aren’t advice for you. They show what researchers measured.
You can’t call a blood rise a health gain. You’ll need a study of how people feel and function.
What makes one form last longer than the other
CJC-1295 starts with 29 building blocks. They come from the body’s growth-hormone message.
The lab record names four changed spots: positions 2, 8, 15, and 27. Those numbers describe the chain, not a health gain.
The four changes slow the body’s breakdown of CJC-1295. The message then lasts hours instead of minutes.
The long form has a small piece that attaches to albumin. Albumin is a common blood protein.
That link keeps half of the long form present for days [9]. The short form wears off within hours.
The short form lacks the added albumin piece. That’s why the timing differs.
The two forms aren’t the same. Sales pages often blur that fact.
Longer action may mean more water gain. It also keeps the growth message active longer [6].
Your liver makes growth factor 1 after growth hormone rises. This growth signal helps many cells grow.
Drug agencies haven’t approved either form. FDA records CJC-1295 in its nominated-but-withdrawn table, with safety concerns still attached; that withdrawal is neither drug approval nor permission to compound it.
Don’t treat both forms as the same compound. Tie any timing claim to the exact form.
What one shot changed in the blood
CJC-1295 attaches to your growth gland. Your gland then releases more growth hormone.
Your liver responds by making growth factor 1, which reaches many body tissues. CJC-1295 raises the liver’s growth message too.
The timing gave researchers a useful finding. CJC-1295 didn’t stop your body’s natural hormone bursts.
The study used healthy men in the 20- to 40-year-old range. Each man received a single shot beneath the skin.
The shot held 60 or 90 micrograms for every kilogram the man weighed. One week later, growth-hormone bursts still came on their usual schedule.
The lowest growth-hormone level rose several times over. The average across each day rose about 46% [10].
The low level rose, but natural bursts continued. That finding came from blood tests.
The blood result doesn’t prove stronger muscles or longer life. A 2025 review makes that limit clear [6].
You can leave the cell code out. You’ll need to focus on what wasn’t tested.
What the lasting blood rise did and didn’t show
CJC-1295 gave the clearest result: a blood rise lasting several days. The healthy adults covered a wide age range.
One shot held 30 or 60 micrograms for every kilogram the adult weighed. Average growth hormone rose 2- to 10-fold.
The rise lasted 6 or more days. Growth factor 1, a liver-made growth signal, rose too.
Growth factor 1 stayed high for 9 to 11 days. With more shots, it remained high for 28 days.
Half of the CJC-1295 stayed in the body for days [9]. Growth factor 1 also stayed high after the shot.
Another study used healthy men. One shot held 60 or 90 micrograms for every kilogram the man weighed.
The lowest growth-hormone level rose several times over. The daily average rose 46%.
Growth factor 1 rose 45% after one week. Natural growth-hormone bursts continued [10].
A smaller study included 11 healthy young men. Some proteins in their blood changed after CJC-1295.
Some blood proteins fell, while part of albumin rose. The study didn’t show better health in the men.
Some proteins used by the immune system rose too. Those changes followed growth factor 1 [8].
Drug testers found CJC-1295 in a seized product. Their lab test could identify it [7].
The original long-form work reached Phase 2, an early human drug test. It studied belly fat tied to a long illness.
That trial stopped after one patient died. The public record doesn’t prove CJC-1295 caused the death.
No Phase 3 test followed. The larger test never checked whether growth factor 1 improved health [6].
You can’t treat long action as a long-term benefit. You’ll need to stay with the measured blood result.
What people report and which harms need watching
People compare the short form with the long form online. Their personal reports aren’t findings from a controlled trial.
Research material may not match its label. A doctor didn’t watch most of these uses.
Deeper sleep is a common good report. Some people notice it during the first week.
Faster recovery also gets mentioned. A report can’t prove CJC-1295 caused either change.
People describe fat loss that took several weeks. Some also report a leaner look while eating less.
Food changes can explain that result. One person’s story can’t sort out the cause.
More daytime energy comes up less often. People also mention sharper focus and firmer skin.
Those claims remain personal stories. No good human trial has checked them.
Water gain is the leading bad report. The long form seems to draw more complaints.
Your face and hands may look puffy. Your fingers may tingle when fluid presses on nerves.
Redness and itching can mark the shot site. People link a head rush with the short form.
Some report tiredness with the long form. Others mention headache or more hunger.
Higher blood sugar also gets reported. Growth hormone can weaken insulin’s effect.
A federal review in 2024 warned that your immune system could attack the compound [6]. A 2025 review kept growth factor 1, the liver-made growth signal, in view.
Keeping growth factor 1 high for days raises a cancer concern. Longer exposure may give harmful cells more time to grow.
Cancer from the rise in growth factor 1 hasn’t appeared in a CJC-1295 study. The concern remains unproved.
Growth hormone also makes your kidneys hold salt and water. That can drive swelling [9].
If you’re nearing diabetes, you have more reason for care. Human safety over years isn’t known.
The short form and long form last for very different times [9][10]. Their similar names hide that key difference.
Sport rules ban CJC-1295. Lab tests can find it [7].
You can’t get trial proof from online reports. You’ll need human studies to answer the safety question.
How the long-acting compound differs from the other three
CJC-1295 causes a long growth-hormone rise. Ipamorelin causes a shorter rise.
The two attach at different places on the growth gland. No sound human trial proves the pair works better.
NAD+ and MOTS-c work inside cells. They don’t begin at the growth gland.
Those are separate ideas about aging. CJC-1295 and growth factor 1, a liver-made signal, haven’t become a proved plan for better health.
CJC-1295 changed blood levels for days. It didn’t prove lasting health gains.
Put that fact first on the four-compound guide. Long action doesn’t mean better health.
Higher hormone levels can’t be your only goal. A study must test how people feel and function.